Showing results (121-130 of 193) with videos related to

Sort By:
Pageof 20
Epidemiology (Cambridge, Mass.)|April 28, 2011
The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodologyJustyna D Kowalska, Nina Friis-Møller, Ole Kirk, et al.
AIDS (London, England)|August 7, 2019
Serious clinical events in HIV-positive persons with chronic kidney diseaseLene Ryom, Jens D Lundgren, Matthew Law, et al.
AIDS (London, England)|March 8, 2016
Improvements over time in short-term mortality following myocardial infarction in HIV-positive individualsCamilla Ingrid Hatleberg, Lene Ryom, Wafaa El-Sadr, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 18, 2018
Body Mass Index and the Risk of Serious Non-AIDS Events and All-Cause Mortality in Treated HIV-Positive Individuals: D: A: D Cohort AnalysisAmit C Achhra, Caroline Sabin, Lene Ryom, et al.
The Journal of Infectious Diseases|December 31, 2009
Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) studySigne Westring Worm, Caroline Sabin, Rainer Weber, et al.
The Journal of Infection|October 20, 2019
Consensus recommendations for resistance testing in the management of chronic hepatitis C virus infection: Public Health England HCV Resistance GroupDaniel Bradshaw, Jean L Mbisa, Anna Maria Geretti, et al.
Plos Medicine|November 8, 2017
Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational studyMark A Boyd, Amanda Mocroft, Lene Ryom, et al.
Journal of Clinical Epidemiology|March 30, 2010
Data linkage reduces loss to follow-up in an observational HIV cohort studyTeresa Hill, Loveleen Bansi, Caroline Sabin, et al.
The Lancet. HIV|May 8, 2018
Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort studyLene Ryom, Jens D Lundgren, Wafaa El-Sadr, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 26, 2009
Is 1 alanine transaminase >200 IU enough to define an alanine transaminase flare in HIV-infected populations? A new definition derived from a large cohort studyLoveleen Bansi, Jo Turner, Richard Gilson, et al.
Pageof 20